Distribuzione geografica
Continente #
EU - Europa 136
Totale 136
Nazione #
IT - Italia 136
Totale 136
Città #
Pavia 131
Milan 4
Arcore 1
Totale 136
Nome #
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial, file e1f104fc-7833-8c6e-e053-1005fe0aa0dd 3
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial, file e1f104fc-79cd-8c6e-e053-1005fe0aa0dd 3
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2, file e1f104fc-7cde-8c6e-e053-1005fe0aa0dd 3
Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era, file e1f104fc-7f09-8c6e-e053-1005fe0aa0dd 3
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study, file e1f104fd-1d52-8c6e-e053-1005fe0aa0dd 3
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease, file e1f104fb-241c-8c6e-e053-1005fe0aa0dd 2
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes, file e1f104fc-7507-8c6e-e053-1005fe0aa0dd 2
Cangrelor use in a 6-year-old patient undergoing complex percutaneous coronary intervention after post-surgical myocardial infarction, file e1f104fc-764a-8c6e-e053-1005fe0aa0dd 2
Short dual antiplatelet therapy: how, when and why, file e1f104fc-7828-8c6e-e053-1005fe0aa0dd 2
Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest, file e1f104fc-782c-8c6e-e053-1005fe0aa0dd 2
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX, file e1f104fc-7931-8c6e-e053-1005fe0aa0dd 2
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: A pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial, file e1f104fc-796c-8c6e-e053-1005fe0aa0dd 2
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease, file e1f104fc-79c9-8c6e-e053-1005fe0aa0dd 2
Apixaban versus warfarin in patients with atrial fibrillation, file e1f104fc-7b1d-8c6e-e053-1005fe0aa0dd 2
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y 12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: The INNOVATE-PCI trial, file e1f104fc-7e41-8c6e-e053-1005fe0aa0dd 2
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting, file e1f104fc-8343-8c6e-e053-1005fe0aa0dd 2
Alirocumab and cardiovascular outcomes after acute coronary syndrome, file e1f104fc-8dee-8c6e-e053-1005fe0aa0dd 2
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial, file e1f104fc-8fd3-8c6e-e053-1005fe0aa0dd 2
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis, file e1f104fd-1d59-8c6e-e053-1005fe0aa0dd 2
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group, file e1f104fd-2094-8c6e-e053-1005fe0aa0dd 2
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study, file 320be58e-7f56-446c-bc23-0a727ed51093 1
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease, file e1f104fa-f248-8c6e-e053-1005fe0aa0dd 1
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience, file e1f104fb-5105-8c6e-e053-1005fe0aa0dd 1
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study., file e1f104fc-686c-8c6e-e053-1005fe0aa0dd 1
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience, file e1f104fc-7502-8c6e-e053-1005fe0aa0dd 1
Rationale and design of the cangrelor versus standard therapy to achieve optimal management of platelet inhibition PHOENIX trial, file e1f104fc-7505-8c6e-e053-1005fe0aa0dd 1
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization, file e1f104fc-7597-8c6e-e053-1005fe0aa0dd 1
Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties, file e1f104fc-7599-8c6e-e053-1005fe0aa0dd 1
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in Non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends, file e1f104fc-75ad-8c6e-e053-1005fe0aa0dd 1
Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial, file e1f104fc-7605-8c6e-e053-1005fe0aa0dd 1
Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: Insights from the CHAMPION percutaneous coronary intervention trial, file e1f104fc-7608-8c6e-e053-1005fe0aa0dd 1
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial, file e1f104fc-760a-8c6e-e053-1005fe0aa0dd 1
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction, file e1f104fc-760d-8c6e-e053-1005fe0aa0dd 1
Promises of PAR-1 inhibition in acute coronary syndrome, file e1f104fc-760f-8c6e-e053-1005fe0aa0dd 1
Thrombin receptor antagonists for the treatment of atherothrombosis: Therapeutic potential of vorapaxar and E-5555, file e1f104fc-7611-8c6e-e053-1005fe0aa0dd 1
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention, file e1f104fc-7625-8c6e-e053-1005fe0aa0dd 1
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis, file e1f104fc-7626-8c6e-e053-1005fe0aa0dd 1
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data, file e1f104fc-767f-8c6e-e053-1005fe0aa0dd 1
A novel approach to systematically implement the universal definition of myocardial infarction: Insights from the CHAMPION PLATFORM trial, file e1f104fc-7784-8c6e-e053-1005fe0aa0dd 1
Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: A systematic review, file e1f104fc-7789-8c6e-e053-1005fe0aa0dd 1
Short-and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: Insights from four validated bleeding scales in the CHAMPION trials, file e1f104fc-77b9-8c6e-e053-1005fe0aa0dd 1
Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes, file e1f104fc-7815-8c6e-e053-1005fe0aa0dd 1
Percutaneous coronary interventions for stable ischemic heart disease in Italy, file e1f104fc-7834-8c6e-e053-1005fe0aa0dd 1
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry, file e1f104fc-792d-8c6e-e053-1005fe0aa0dd 1
Aspirin Desensitization in Patients with Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease)., file e1f104fc-7933-8c6e-e053-1005fe0aa0dd 1
Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration, file e1f104fc-7967-8c6e-e053-1005fe0aa0dd 1
Determining myocardial infarction after PCI: CK-MB, troponin, both, or neither?, file e1f104fc-7969-8c6e-e053-1005fe0aa0dd 1
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study, file e1f104fc-7990-8c6e-e053-1005fe0aa0dd 1
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes, file e1f104fc-7991-8c6e-e053-1005fe0aa0dd 1
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome, file e1f104fc-7992-8c6e-e053-1005fe0aa0dd 1
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: The GLOBAL LEADERS Adjudication Sub-StudY (GLASSY), file e1f104fc-7994-8c6e-e053-1005fe0aa0dd 1
Acute Cardiovascular Care 2019, file e1f104fc-7995-8c6e-e053-1005fe0aa0dd 1
Optimised care of elderly patients with acute coronary syndrome, file e1f104fc-79d0-8c6e-e053-1005fe0aa0dd 1
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes, file e1f104fc-7a3f-8c6e-e053-1005fe0aa0dd 1
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study, file e1f104fc-7a41-8c6e-e053-1005fe0aa0dd 1
Use of biomarkers to predict specific causes of death in patients with Atrial fibrillation: Insights from the Aristotle Trial, file e1f104fc-7a43-8c6e-e053-1005fe0aa0dd 1
Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed, file e1f104fc-7a45-8c6e-e053-1005fe0aa0dd 1
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial, file e1f104fc-7a47-8c6e-e053-1005fe0aa0dd 1
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor?, file e1f104fc-7a86-8c6e-e053-1005fe0aa0dd 1
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention: Results from CHAMPION PHOENIX, file e1f104fc-7a88-8c6e-e053-1005fe0aa0dd 1
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial, file e1f104fc-7ac2-8c6e-e053-1005fe0aa0dd 1
Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the augustus trial, file e1f104fc-7aef-8c6e-e053-1005fe0aa0dd 1
Is the use of risk scores an indicator of guideline adherence for patients with acute coronary syndromes? Insights from the EYESHOT registry, file e1f104fc-7c82-8c6e-e053-1005fe0aa0dd 1
Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial, file e1f104fc-7cc6-8c6e-e053-1005fe0aa0dd 1
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial, file e1f104fc-7cc9-8c6e-e053-1005fe0aa0dd 1
Spontaneous MI after non-ST-segment elevation acute coronary syndrome managed without revascularization: The TRILOGY ACS trial, file e1f104fc-7ccb-8c6e-e053-1005fe0aa0dd 1
Bivalirudin or unfractionated heparin in acute coronary syndromes, file e1f104fc-7ccd-8c6e-e053-1005fe0aa0dd 1
Bivalirudin or unfractionated heparin in acute coronary syndromes, file e1f104fc-7cce-8c6e-e053-1005fe0aa0dd 1
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study, file e1f104fc-7ccf-8c6e-e053-1005fe0aa0dd 1
Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial, file e1f104fc-7cd1-8c6e-e053-1005fe0aa0dd 1
Glycoprotein IIb/IIIa receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER trial), file e1f104fc-7cd3-8c6e-e053-1005fe0aa0dd 1
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial, file e1f104fc-7cd4-8c6e-e053-1005fe0aa0dd 1
Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function, file e1f104fc-7cdf-8c6e-e053-1005fe0aa0dd 1
Consistent Reduction in Periprocedural Myocardial Infarction with Cangrelor as Assessed by Multiple Definitions: Findings from CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition), file e1f104fc-7ce2-8c6e-e053-1005fe0aa0dd 1
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: A randomised multicentre trial, file e1f104fc-7ce4-8c6e-e053-1005fe0aa0dd 1
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-st-segment elevation acute coronary syndrome (from the tracer trial), file e1f104fc-7ce5-8c6e-e053-1005fe0aa0dd 1
Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX), file e1f104fc-7ce8-8c6e-e053-1005fe0aa0dd 1
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER trial), file e1f104fc-7cec-8c6e-e053-1005fe0aa0dd 1
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials, file e1f104fc-7d57-8c6e-e053-1005fe0aa0dd 1
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasivemanagement: Secondary analysis of a randomized clinical trial, file e1f104fc-7d5b-8c6e-e053-1005fe0aa0dd 1
Limitations of using cardiac catheterization rates to assess the quality of care for patients with non-ST-segment elevation myocardial infarction, file e1f104fc-7dac-8c6e-e053-1005fe0aa0dd 1
Effect of platelet inhibition with Cangrelor during PCI on ischemic events, file e1f104fc-7e3b-8c6e-e053-1005fe0aa0dd 1
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI), file e1f104fc-7e42-8c6e-e053-1005fe0aa0dd 1
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial, file e1f104fc-7eed-8c6e-e053-1005fe0aa0dd 1
Antithrombotic Therapy in Patients With Acute Coronary Syndrome Complicated by Cardiogenic Shock or Out-Of-Hospital Cardiac Arrest: A Joint Position Paper From the European Society of Cardiology (ESC) Working Group on Thrombosis, in Association With the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI), file e1f104fc-7f19-8c6e-e053-1005fe0aa0dd 1
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS, file e1f104fc-7f40-8c6e-e053-1005fe0aa0dd 1
Parenteral antithrombotic therapy during primary percutaneous coronary intervention, file e1f104fc-7fa3-8c6e-e053-1005fe0aa0dd 1
Will PIONEER AF-PCI change my practice?, file e1f104fc-81e5-8c6e-e053-1005fe0aa0dd 1
Peri-procedural myocardial infarction and troponism: A quick journey through the land of confusion, file e1f104fc-8222-8c6e-e053-1005fe0aa0dd 1
PAR-1 inhibitors: A novel class of antiplatelet agents for the treatment of patients with atherothrombosis, file e1f104fc-8340-8c6e-e053-1005fe0aa0dd 1
Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes, file e1f104fc-84c2-8c6e-e053-1005fe0aa0dd 1
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis, file e1f104fc-8ab2-8c6e-e053-1005fe0aa0dd 1
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial, file e1f104fc-8ab6-8c6e-e053-1005fe0aa0dd 1
The future for the Acute Cardiovascular Care Congress we shall find together, file e1f104fc-dc87-8c6e-e053-1005fe0aa0dd 1
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis, file e1f104fc-e2dc-8c6e-e053-1005fe0aa0dd 1
Composition, structure, and function of heart teams: A joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization, file e1f104fd-15e4-8c6e-e053-1005fe0aa0dd 1
Incidence of ventricular arrhythmias and 1-year predictors of mortality in patients treated with implantable cardioverter-defibrillator undergoing generator replacement, file e1f104fd-160a-8c6e-e053-1005fe0aa0dd 1
The prognostic value of serial troponin measurements in patients admitted for COVID-19, file e1f104fd-163e-8c6e-e053-1005fe0aa0dd 1
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study, file e1f104fd-1642-8c6e-e053-1005fe0aa0dd 1
Sotagliflozin in patients with diabetes and recent worsening heart failure, file e1f104fd-1644-8c6e-e053-1005fe0aa0dd 1
Totale 125
Categoria #
all - tutte 142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0000 00 00 01087
2020/202120 10000 00 01 9000
2021/202223 22100 00 00 0000
2022/20233 0003 00 00 0000
Totale 136